Guggenheim initiated coverage of Celcuity (CELC) with a Buy rating and $110 price target
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CELC:
- Short Report: Celcuity short interest at two-year high
- Celcuity’s Enhanced Financial Flexibility and Strategic Progress Justify Buy Rating
- Celcuity Expands Credit Facility to $500 Million
- Celcuity Inc. Earnings Call: Clinical Progress and Financial Fortification
- Celcuity’s Gedatolisib Gains Momentum with FDA’s RTOR Program and Promising Phase 3 Trial Results